Effects of Garlic Supplements on Drug Metabolism
Garlic Metabolism and Cytochrome P450 Modulation
2 other identifiers
observational
80
1 country
1
Brief Summary
This study will determine whether garlic supplements affect the way certain drugs are processed in the body.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2005
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 20, 2005
CompletedFirst Posted
Study publicly available on registry
July 22, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedJanuary 1, 2010
December 1, 2009
July 20, 2005
December 30, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood plasma and urine samples
3 months
Secondary Outcomes (1)
Blood plasma and breath samples.
3 months
Interventions
Eligibility Criteria
Healthy volunteers
You may qualify if:
- Body mass index (BMI) between 20 and 32
- Able to read and understand English
- MUST LIVE WITHIN THE SEATTLE, WA AREA.
You may not qualify if:
- Current use of herbal medicines other than oral contraceptives
- History of cardiopulmonary, liver, renal or endocrine disease
- Allergy or sensitivity to any of the drugs that will be used in the probe cocktails or the garlic supplements
- Daily consumption of vegetables with a high allium content, including garlic, shallots, leeks, and chives
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Biospecimen
Whole blood, urine
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Danny D. Shen, PhD
Fred Hutchinson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 20, 2005
First Posted
July 22, 2005
Study Start
July 1, 2005
Study Completion
March 1, 2009
Last Updated
January 1, 2010
Record last verified: 2009-12